Full chimaeric <scp>CAR</scp> . <scp>CIK</scp> from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers-Reference-Cited by-同舟云学术

Full chimaeric CAR . CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers

Published:2022-09-26 Issue:1 Volume:200 Page:64-69
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Circosta Paola¹²,Donini Chiara³⁴^ORCID,Gallo Susanna⁵,Giraudo Lidia³,Gammaitoni Loretta³,Rotolo Ramona³⁴,Galvagno Federica³⁴,Capellero Sonia³⁴,Basiricò Marco⁶,Casucci Monica⁷,Aglietta Massimo³⁴,Ferrero Ivana⁶,Fagioli Franca⁶⁸,Cignetti Alessandro⁹,Carnevale‐Schianca Fabrizio³,Leuci Valeria³^ORCID,Sangiolo Dario³⁴^ORCID

Affiliation:

1. Department of Clinical and Biological Sciences University of Turin Turin Italy

2. Molecular Biotechnology Center University of Turin Turin Italy

3. Candiolo Cancer Institute, FPO‐IRCCS Candiolo Turin Italy

4. Department of Oncology University of Turin Turin Italy

5. Hematology Unit ASL Torino 4 Turin Italy

6. Stem Cell Transplantation and Cellular Therapy Laboratory, Paediatric Onco‐Haematology Division Regina Margherita Children's Hospital, City of Health and Science of Turin Turin Italy

7. Innovative Immunotherapies Unit ‐ Division of Immunology Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute Milan Italy

8. Department of Public Health and Paediatrics University of Turin Turin Italy

9. Division of Hematology and Cell Therapy A.O. Ordine Mauriziano Turin Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18469

Reference17 articles.

1. Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party